Nuvation Bio NUVB Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's cash provided by (used in) financing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's cash provided by (used in) financing activity, including discontinued operation?
- Nuvation Bio (NUVB) reported cash provided by (used in) financing activity, including discontinued operation of $44K in Q1 2026.
- How has Nuvation Bio's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
- Nuvation Bio's cash provided by (used in) financing activity, including discontinued operation decreased by 92.0% year-over-year, from $548K to $44K.
- What is the long-term trend for Nuvation Bio's cash provided by (used in) financing activity, including discontinued operation?
- Over 2 years (2021 to 2025), Nuvation Bio's cash provided by (used in) financing activity, including discontinued operation has grown at a -43.1% compound annual growth rate (CAGR), from $625.56M to $202.54M.
- What does cash provided by (used in) financing activity, including discontinued operation mean?
- This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.